Erratum to: Curr Atheroscler Rep
DOI 10.1007/s11883-011-0202-3
The Disclosure section of the article “Resveratrol in the Prevention and Treatment of Coronary Artery Disease” should read as follows: L.M. Chu: none; A.D. Lassaletta: none; M.P. Robich: supported by 5T32-HL007734; F.W. Selke: consultant for NovoNordisk and Cubist Pharmaceuticals, expert testimony for Pfizer in litigation regarding Celebrex.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/ 10.1007/s11883-011-0202-3
Rights and permissions
About this article
Cite this article
Chu, L.M., Lassaletta, A.D., Robich, M.P. et al. Erratum to: Resveratrol in the Prevention and Treatment of Coronary Artery Disease. Curr Atheroscler Rep 13, 508 (2011). https://doi.org/10.1007/s11883-011-0213-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11883-011-0213-0